FindTrial
Sign In

Microwave ablation versus radiofrequency ablation for hepatocellular carcinoma in patients with decompensated cirrhosis

Comparison of microwave ablation and radiofrequency ablation in the treatment of hepatocellular carcinoma in patients with decompensated cirrhosis: a retrospective study based on medical records.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300076222
Enrollment
Unknown
Registered
2023-09-27
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

MWA group:Nil
RFA group:Nil

Sponsors

Shandong Provincial Hospital Affiliated to Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients older than 18 years old; 2. Patients with 3 tumor nodes at most and Q <=5cm each; 3. Patients with decompensated cirrhosis; 4. Patients without signs of vascular or bile duct invasion; 5. Patients without extrahepatic metastasis;

Exclusion criteria

Exclusion criteria: 1. Patients who did not achieve complete ablation after thermal ablation (complete ablation is defined as: 1 month after ablation, there was no irregular or nodular enhancement in the ablation focus or edge under the observation of enhanced CT or enhanced MRI; 2. Patients with other serious combined diseases such as cardiopulmonary damage or renal failure.

Design outcomes

Primary

MeasureTime frame
Overall surviva;—

Secondary

MeasureTime frame
progression-free survival;hospital stay;complications;progression beyond Milan criteria;—

Countries

China

Contacts

Public ContactQiang Zhu

Shandong Provincial Hospital Affiliated to Shandong First Medical University

zhuqiang@sdu.edu.cn+86 151 6888 7780

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026